Berglund:Focus - Revision history

Amahady: Replacing page with 'please see:
http://chemistry.uoregon.edu/fac.html?berglund'

2012-01-31T17:59:01Z

Replacing page with 'please see:<br> http://chemistry.uoregon.edu/fac.html?berglund'

←Older revision		Revision as of 17:59, 31 January 2012
Line 1:		Line 1:
-	~~We are an RNA lab involved in studying RNA/Protein interactions.~~<br>	+	please see:<br>
-		+	http://chemistry.uoregon.edu/fac.html?berglund
-	~~One aspect of understanding the splicing of RNA is to study various proteins involved in the splicing of the 5' or 3' end of introns and looking at the mechanisms involved in~~	+
-	~~binding and recognition~~. ~~We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals~~.~~<br><br>~~	+
-		+
-	~~Another aspect is to study particular proteins involved in disease associated with alternative splicing~~. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>	+
-		+
-	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>	+

Amahady at 22:53, 19 February 2008

2008-02-19T22:53:49Z

←Older revision		Revision as of 22:53, 19 February 2008
Line 1:		Line 1:
-	We are an RNA lab involved in studying RNA/Protein ~~interactions as well as RNA/Au~~ interactions.	+	We are an RNA lab involved in studying RNA/Protein interactions.<br>

-	~~We have two major goals.~~	+	One aspect of understanding the splicing of RNA is to study various proteins involved in the splicing of the 5' or 3' end of introns and looking at the mechanisms involved in
-		+
-	~~1) Understanding~~ splicing of RNA.	+
-		+
-	~~One aspect~~ is to study various proteins involved in the splicing of the 5' or 3' end of introns and looking at the mechanisms involved in	+
	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.<br><br>		binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.<br><br>

Line 11:		Line 7:

	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>		A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>
-
-	~~2) Nanoparticles~~
-
-	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 23:43, 21 June 2007

2007-06-21T23:43:41Z

←Older revision		Revision as of 23:43, 21 June 2007
Line 5:		Line 5:
	1) Understanding splicing of RNA.		1) Understanding splicing of RNA.

-	One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in	+	One aspect is to study various proteins involved in the splicing of the 5' or 3' end of introns and looking at the mechanisms involved in
	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.<br><br>		binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.<br><br>

	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>		Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>

-	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of ~~sequenceelements~~ within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>	+	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>

	2) Nanoparticles		2) Nanoparticles

	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.		We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 00:19, 11 April 2007

2007-04-11T00:19:04Z

←Older revision		Revision as of 00:19, 11 April 2007
Line 5:		Line 5:
	1) Understanding splicing of RNA.		1) Understanding splicing of RNA.

-	One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in~~<br>~~	+	One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in
-	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray~~<br>~~ crystallography in order to achieve our goals.<br><br>	+	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.<br><br>

-	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that ~~<br>~~is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related ~~<br>~~splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>	+	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>

-	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of ~~sequence<br> elements~~ within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both ~~<br>~~in vivo and in vitro effects of these splicing elements.<br><br>	+	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequenceelements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.<br><br>

	2) Nanoparticles		2) Nanoparticles

-	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped ~~<br>~~and sized gold nanoparticles using RNA as the reaction driver/director.	+	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 00:18, 11 April 2007

2007-04-11T00:18:05Z

←Older revision		Revision as of 00:18, 11 April 2007
Line 6:		Line 6:

	One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in<br>		One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in<br>
-	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.	+	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.<br><br>

-	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.	+	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.<br><br>

-	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.	+	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.<br><br>

	2) Nanoparticles		2) Nanoparticles

	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.		We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 00:17, 11 April 2007

2007-04-11T00:17:46Z

←Older revision		Revision as of 00:17, 11 April 2007
Line 8:		Line 8:
	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.		binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.

-	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.	+	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.

-	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.	+	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.

	2) Nanoparticles		2) Nanoparticles

-	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.	+	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 00:17, 11 April 2007

2007-04-11T00:17:09Z

←Older revision		Revision as of 00:17, 11 April 2007
Line 5:		Line 5:
	1) Understanding splicing of RNA.		1) Understanding splicing of RNA.

-	A) One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in<br>	+	One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in<br>
	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.		binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.

-	B) Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.	+	Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.

-	C) A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.	+	A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.

	2) Nanoparticles		2) Nanoparticles

-	A) We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.	+	We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady at 00:16, 11 April 2007

2007-04-11T00:16:21Z

←Older revision		Revision as of 00:16, 11 April 2007
Line 1:		Line 1:
-
	We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions.		We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions.

Line 6:		Line 5:
	1) Understanding splicing of RNA.		1) Understanding splicing of RNA.

-	A) One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.	+	A) One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in<br>
		+	binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray<br> crystallography in order to achieve our goals.

-	B) Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.	+	B) Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that <br>is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related <br>splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.

-	C) A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.	+	C) A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence<br> elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both <br>in vivo and in vitro effects of these splicing elements.

	2) Nanoparticles		2) Nanoparticles

-	A) We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.	+	A) We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped <br>and sized gold nanoparticles using RNA as the reaction driver/director.

Amahady: New page: We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions. We have two major goals. 1) Understanding splicing of RNA. A) One aspect is...

2007-04-11T00:15:17Z

New page: We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions. We have two major goals. 1) Understanding splicing of RNA. A) One aspect is...

New page

We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions.

We have two major goals.

1) Understanding splicing of RNA.

A) One aspect is to study various proteins involved in the splicing of the 5' or 3'end of introns and looking at the mechanisms involved in binding and recognition. We use footprinting, GST-pulldowns, binding gels, in vitro and in vivo splicing, northerns, westerns and x-ray crystallography in order to achieve our goals.

B) Another aspect is to study particular proteins involved in disease associated with alternative splicing. In particular we study MBNL that is involved in myotonic dystrophy. We also study particular genetic sequences believed to be involved in alternative or disease related splicing. As a side project we are investigating competitive binders to CUG repeats to block MBNL from binding.

C) A third aspect is that we do computational analysis of entire genomes of particular species looking for conservation of sequence elements within introns associated with both constitutive and alternative splicing. Information from these analyses can be used to study both in vivo and in vitro effects of these splicing elements.

2) Nanoparticles

A) We have teamed up with a material sciences group here at the University of Oregon to study the production of specificially shaped and sized gold nanoparticles using RNA as the reaction driver/director.

Berglund:Focus - Revision history

Amahady: Replacing page with 'please see: http://chemistry.uoregon.edu/fac.html?berglund'

Amahady at 22:53, 19 February 2008

Amahady at 23:43, 21 June 2007

Amahady at 00:19, 11 April 2007

Amahady at 00:18, 11 April 2007

Amahady at 00:17, 11 April 2007

Amahady at 00:17, 11 April 2007

Amahady at 00:16, 11 April 2007

Amahady: New page: We are an RNA lab involved in studying RNA/Protein interactions as well as RNA/Au interactions. We have two major goals. 1) Understanding splicing of RNA. A) One aspect is...

Amahady: Replacing page with 'please see:
http://chemistry.uoregon.edu/fac.html?berglund'